Revenue for Danaher (DHR)
According to Danaher's latest reported financial statements, the company's current revenue (TTM) is $24.78B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

DHR
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$24.78B
YoY change
+2.9%
5Y CAGR
+2.0%
Peak year (2021)
$29.45B
Cumulative revenue
$417.97B
Revenue history chart for Danaher (DHR) from 1985 to 2025
Revenue history table for Danaher (DHR) from 1985 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $24.57B | +2.9% | ||
| 2024 | $23.88B | -0.1% | ||
| 2023 | $23.89B | -10.3% | ||
| 2022 | $26.64B | -9.5% | ||
| 2021 | $29.45B | +32.2% | ||
| 2020 | $22.28B | +24.4% | ||
| 2019 | $17.91B | +5.1% | ||
| 2018 | $17.05B | -7.0% | ||
| 2017 | $18.33B | +8.6% | ||
| 2016 | $16.88B | +17.0% | ||
| 2015 | $14.43B | -27.5% | ||
| 2014 | $19.91B | +4.2% | ||
| 2013 | $19.12B | +4.7% | ||
| 2012 | $18.26B | +13.5% | ||
| 2011 | $16.09B | +21.9% | ||
| 2010 | $13.20B | +18.0% | ||
| 2009 | $11.18B | -11.9% | ||
| 2008 | $12.70B | +15.2% | ||
| 2007 | $11.03B | +14.9% | ||
| 2006 | $9.60B | +20.2% | ||
| 2005 | $7.98B | +15.9% | ||
| 2004 | $6.89B | +30.1% | ||
| 2003 | $5.29B | +15.7% | ||
| 2002 | $4.58B | +21.0% | ||
| 2001 | $3.78B | +0.1% | ||
| 2000 | $3.78B | +18.2% | ||
| 1999 | $3.20B | +9.9% | ||
| 1998 | $2.91B | +41.9% | ||
| 1997 | $2.05B | +13.2% | ||
| 1996 | $1.81B | +21.9% | ||
| 1995 | $1.49B | +15.4% | ||
| 1994 | $1.29B | +20.8% | ||
| 1993 | $1.07B | +12.4% | ||
| 1992 | $949.00M | +14.1% | ||
| 1991 | $831.60M | -1.0% | ||
| 1990 | $840.00M | +12.1% | ||
| 1989 | $749.10M | +4.8% | ||
| 1988 | $714.60M | +16.2% | ||
| 1987 | $615.00M | +37.9% | ||
| 1986 | $446.00M | +49.7% | ||
| 1985 | $298.00M | — |
Revenue values are taken from Danaher's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Danaher (DHR) revenue totalled $24.57B – edged up 2.9% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Danaher revenue compounded at +2.0% per year, with the latest reading among the more recent periods of the dataset.
Danaher revenue declined from $29.45B in 2021 to $24.57B in 2025, a 16.6% drawdown.
Across the available history, revenue reached its high of $29.45B in 2021 and its low of $298.00M in 1985.
Among 8 Healthcare peers, Danaher (DHR) ranks 9th; the peer median for revenue is $65.09B.
Danaher Revenue by Year
Danaher Revenue 2025: $24.57B
Danaher revenue in 2025 was $24.57B, edged up 2.9% from 2024.
Danaher Revenue 2024: $23.88B
Danaher revenue in 2024 was $23.88B, edged down 0.1% below 2023.
Danaher Revenue 2023: $23.89B
Danaher revenue in 2023 was $23.89B, declined 10.3% below 2022.
Danaher Revenue 2022: $26.64B
Danaher revenue in 2022 was $26.64B, declined 9.5% below 2021.
Danaher Revenue 2021: $29.45B
Danaher revenue in 2021 was $29.45B.
See more financial history for Danaher (DHR).
Sector peers — Revenue
Companies in the same sector as Danaher, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Danaher's revenue?
- Latest reported revenue for Danaher (DHR) is $24.78B (period ending March 27, 2026).
How has Danaher revenue changed year-over-year?
- Danaher (DHR) revenue changed +2.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Danaher revenue?
- Danaher (DHR) revenue compound annual growth rate is +2.0% over the most recent 5 years available.
When did Danaher revenue hit its highest annual value?
- Danaher revenue reached its highest annual value of $29.45B in 2021.
What was Danaher revenue in 2024?
- Danaher (DHR) revenue in 2024 was $23.88B.
What was Danaher revenue in 2025?
- Danaher (DHR) revenue in 2025 was $24.57B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DHR Overview
Company profile, financial tools, and key metrics
DHR Revenue Counter
Earns $785.71 every second. See per minute, hour, and day.
DHR Earnings Counter
Earns $116.98 per second net profit. See per minute, hour, and day.
DHR Economic Scale
Exceeds Guyana's GDP. Compare with world economies.
DHR What If Invested
What if you had invested $1,000? See historical returns from any date.
DHR How It Makes Money
Discover visual breakdown of $24.78B in revenue — where it comes from and where it goes.
DHR Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DHR Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DHR Daily Price Character
Balanced · 45.2% historical win rate (green days). Streaks & record days.
DHR Buybacks
1.57% TTM buyback yield. Shareholder yield & SBC comparison.
DHR Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
DHR Dividend Profile
Yield: 0.76%. Safety: 4/8. See full history.
DHR Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
DHR Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.